What is the ticker symbol for Halozyme Therapeutics, Inc.?

The ticker symbol for Halozyme Therapeutics, Inc. is NASDAQ:HALO

Does Halozyme Therapeutics, Inc. pay dividends?

No, Halozyme Therapeutics, Inc. does not pay dividends

What sector is Halozyme Therapeutics, Inc. in?

Halozyme Therapeutics, Inc. is in the Healthcare sector

What industry is Halozyme Therapeutics, Inc. in?

Halozyme Therapeutics, Inc. is in the Biotechnology industry

What country is Halozyme Therapeutics, Inc. based in?

Halozyme Therapeutics, Inc. is headquartered in United States

When did Halozyme Therapeutics, Inc. go public?

Halozyme Therapeutics, Inc. initial public offering (IPO) was on March 16, 2004

Is Halozyme Therapeutics, Inc. in the S&P 500?

No, Halozyme Therapeutics, Inc. is not included in the S&P 500 index

Is Halozyme Therapeutics, Inc. in the NASDAQ 100?

No, Halozyme Therapeutics, Inc. is not included in the NASDAQ 100 index

Is Halozyme Therapeutics, Inc. in the Dow Jones?

No, Halozyme Therapeutics, Inc. is not included in the Dow Jones index

When was Halozyme Therapeutics, Inc. last earnings report?

Halozyme Therapeutics, Inc.'s most recent earnings report was on November 3, 2025

When does Halozyme Therapeutics, Inc. report earnings?

The next expected earnings date for Halozyme Therapeutics, Inc. is February 17, 2026

HALO Stock Financials, Chart, Sentiment & Profile

Profile

Company profile for Halozyme Therapeutics, Inc. (HALO)
Metric	Value
Full Name	Halozyme Therapeutics, Inc.
Ticker	NASDAQ: HALO
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Mar 16, 2004
Indexes	Not included
Website	halozyme.com
Employees	350

Key Metrics

Halozyme Therapeutics, Inc. Key Details
Metric	Date	Value
Price	Feb 4, 26	$77.93
Price, 1D Change	Feb 4, 26	+1.90%
	Feb 4, 26	$9B
	Feb 4, 26	-
	Feb 4, 26	16.38
	Feb 4, 26	0.53
	Dec 31, 24	$1B
Revenue, 1Y Change	Dec 31, 24	+22.44%
	Dec 31, 24	$3.43
EPS, 1Y Change	Dec 31, 24	+63.52%

Events

Halozyme Therapeutics, Inc. Events
Metric	Date	Value
Next Earnings	Feb 17, 26
Last Qtr. Earnings	Nov 3, 25
Last Ann. Earnings	Feb 18, 25
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	Apr 30, 07	HTI
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

HALO Estimates
Metric	Date	Value
	Dec 31, 24	$3.43
EPS Estimate	Feb 17, 26	$6.48
EPS Est. Change	Feb 17, 26	+88.85%
	Dec 31, 24	$1.02B
Revenue Estimate	Feb 17, 26	$1.39B
Revenue Est. Change	Feb 17, 26	+37.28%
Current Price	Feb 4, 26	$77.93
Price Target	-	$77.00
Price Tgt. Change	-	-1.19%

🔒 Log In To Unlock Full Data

EPS

HALO EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2023	$2.77	$2.10	-24.25%
2024	$4.13	$3.43	-16.87%
2025	$6.48	N/A	+88.85%
2026	$8.21	N/A	+139.34%

Revenue

HALO revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2023	$830.66M	$829.25M	-0.17%
2024	$1.00B	$1.02B	+1.21%
2025	$1.39B	N/A	+37.28%
2026	$1.77B	N/A	+74.05%

🔒 Log In To Unlock Full Data

Performance

HALO Performance
Metric	Date	Value
Price, 1Y	Feb 4, 26	+35.22%
Price, 3Y	Feb 4, 26	+48.02%
	Feb 4, 26	+29.14%
	Feb 4, 26	+28.79%
	Dec 31, 24	+22.44%
	Dec 31, 24	+129.03%
	Dec 31, 24	+63.52%
	Dec 31, 24	+25.08%

🔒 Log In To Unlock Full Data

Technical Indicators

HALO Technical Indicators
Metric	Date	Value
Current Price	Feb 4, 26	$77.93
	Feb 4, 26	$64.83
SMA 200 vs Price	Feb 4, 26	-16.81%
	Feb 4, 26	$69.32
SMA 50 vs Price	Feb 4, 26	-11.05%
	Feb 4, 26	0.53
	Feb 4, 26	$2.36
	Feb 4, 26	68.27
	Feb 4, 26	36.43%
	Feb 4, 26	42.13%

Dividends

HALO Dividends
Metric	Date	Value
	N/A	-
Upcoming	N/A	N/A
	Feb 4, 26	-
	Dec 31, 24	-
	Dec 31, 24	$0.00
	Dec 31, 24	0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

HALO Income & Profitability
Metric	Date	Value
	Dec 31, 24	$1.02B
	Dec 31, 24	$3.43
	Dec 31, 24	$784.86M
	Dec 31, 24	77.30%
	Dec 31, 24	$551.48M
	Dec 31, 24	54.32%
	Dec 31, 24	$444.09M
	Dec 31, 24	43.74%
	Dec 31, 24	$656.54M

🔒 Log In To Unlock Full Data

Financial Health

HALO Financial Health
Metric	Date	Value
	Dec 31, 24	4.14
	Dec 31, 24	7.80
	Dec 31, 24	6.78
	Dec 31, 24	-
	Sep 30, 25	8
	Feb 4, 26	5.16

Valuations

HALO Valuations
Metric	Date	Value
	Feb 4, 26	16.38
	Feb 4, 26	7.37
	Feb 4, 26	18.19
	Feb 4, 26	12.17
	N/A	-

Balance Sheet

HALO Balance Sheet
Metric	Date	Value
	Dec 31, 24	$363.82M
	Dec 31, 24	$596.07M
	Dec 31, 24	$2.16B
	Dec 31, 24	$1.09B
	Dec 31, 24	$1.80B
	Dec 31, 24	$139.10M
	Dec 31, 24	$1.54B
	Dec 31, 24	$7.05M
	Dec 31, 24	$10.25M

Expenses

HALO Expenses
Metric	Date	Value
	Dec 31, 24	$463.85M
	Dec 31, 24	$304.43M
	Dec 31, 24	$230.47M
	Dec 31, 24	$0.00
	Dec 31, 24	$81.31M
	Dec 31, 24	$0.00
	Dec 31, 24	$113.04M

Cash Flow

HALO Cash Flow
Metric	Date	Value
	Dec 31, 24	$479.06M
	Dec 31, 24	-$262.72M
	Dec 31, 24	-$218.86M
	Dec 31, 24	$10.70M
	Dec 31, 24	$468.37M

Recent analyst updates

HALO Recent analyst updates
Metric	Date	Value
TD Cowen	Jan 8, 26	→
HC Wainwright & Co.	Dec 19, 25	→
HC Wainwright & Co.	Nov 28, 25	→
Goldman Sachs	Nov 18, 25	→
Citizens	Nov 4, 25	→
JP Morgan	Oct 27, 25	→
Morgan Stanley	Oct 20, 25	→
HC Wainwright & Co.	Oct 15, 25	→
Leerink Partners	Oct 14, 25	→
HC Wainwright & Co.	Oct 2, 25	→

Analyst sentiment

Institutional ownership

Screeners with HALO

FAQ

What is the ticker symbol for Halozyme Therapeutics, Inc.?
The ticker symbol for Halozyme Therapeutics, Inc. is NASDAQ:HALO
Does Halozyme Therapeutics, Inc. pay dividends?
No, Halozyme Therapeutics, Inc. does not pay dividends
What sector is Halozyme Therapeutics, Inc. in?
Halozyme Therapeutics, Inc. is in the Healthcare sector
What industry is Halozyme Therapeutics, Inc. in?
Halozyme Therapeutics, Inc. is in the Biotechnology industry
What country is Halozyme Therapeutics, Inc. based in?
Halozyme Therapeutics, Inc. is headquartered in United States
When did Halozyme Therapeutics, Inc. go public?
Halozyme Therapeutics, Inc. initial public offering (IPO) was on March 16, 2004
Is Halozyme Therapeutics, Inc. in the S&P 500?
No, Halozyme Therapeutics, Inc. is not included in the S&P 500 index
Is Halozyme Therapeutics, Inc. in the NASDAQ 100?
No, Halozyme Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Halozyme Therapeutics, Inc. in the Dow Jones?
No, Halozyme Therapeutics, Inc. is not included in the Dow Jones index
When was Halozyme Therapeutics, Inc. last earnings report?
Halozyme Therapeutics, Inc.'s most recent earnings report was on November 3, 2025
When does Halozyme Therapeutics, Inc. report earnings?
The next expected earnings date for Halozyme Therapeutics, Inc. is February 17, 2026

Data Sources & References

HALO Official Website halozyme.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1159036/000119312525230348/0001193125-25-230348-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1159036/000115903625000010/0001159036-25-000010-index.htm
HALO Profile on Yahoo Finance finance.yahoo.com/quote/HALO
HALO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/halo